Bilaal.Raja
Company record

MDT  Medtronic plc

Trailing twelve months to 2026-07-31, as filed 2026-09-03 and not restated since.
Healthcare

Scale

Market cap
$110.6bn
Revenue TTM
$37.5bn
Net income TTM
$5.2bn
Free cash flow
$6.1bn
Composite score
66.9
Sector rank
#105

Valuation

P / E
21.1
EV / EBITDA
10.7
EV / sales
2.8
FCF yield
5.55%
Yield vs 10-yr
-0.55pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
13.9%
EBITDA margin
25.9%
ROE
10.4%
ROIC
15.4%
Revenue growth
9.8%

Insider activity, last 90 days

Net open-market
$-0.40m
Buyers
0
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The following is a summary of net sales, diluted earnings per share, and operating cash flow for the three months ended July 31, 2026: 36 GAAP to Non-GAAP Reconciliations The tables below present our GAAP to non-GAAP reconciliations for the three months ended July 31, 2026 and July 25, 2025: (1) The charges primarily relate to employee termination benefits, facility related and contract termination costs, and asset write offs. …Medtronic plc, 10-Q, period ended 2026-07-31, filed 2026-09-03

Read the full passage →